Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

Male Birth Control Coming Right Up!


By

Ben Yakas

Published Jul 21, 2011

Modified Jul 21, 2011


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .


By

Ben Yakas

Published Jul 21, 2011

Modified Jul 21, 2011


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

It seems that men don't feel empowered anymore when it comes to their sperm—faced with the Sophie's Choice of wearing condoms or getting a vasectomy (or not having sex, or, God forbid, having an adult conversation with a partner about other ways of preventing conception), men across the nation are demanding more control over their reproductive systems. Science has heard their cries, and responded with a new birth control pill, currently being tested in Indonesia, that makes sperm incapable of entering an egg.

PBS profiled the new drug in a piece last night (which you can watch here)—the plant from which the drug has been derived, gandarusa, doesn't alter male hormones, but rather changes the chemistry on the tip of each individual spermatozoa, making them unable to penetrate the egg...and we can't wait to use that pickup line. Best of all, besides providing all sorts of sexy conversation starters, the pill's effect is not permanent—on average, men were fertile again two months after they took the pill.

While scientists are optimistic that gandarusa will be available in Indonesian stores as early as next year, they don't know when it might come to the U.S., because the strict regulations of the FDA would require years of more testing. Similarly, there is another form of male contraception being worked on here in the U.S.: reversible inhibition of sperm under guidance, or RISUG. A synthetic substance is injected in the vas deferens, which stops most sperm from getting out: "It mostly blocks the tube, but also kills any sperm that get past. It's almost like a filter," said Elaine Lissner, director of the nonprofit Male Contraception Information Project. It has also proven to be reversible in animal trials thus far, a very important selling point for men.

Of course, it's important to keep in mind that none of these male contraceptives take into account, or address, STDs or STIs. And there is one form of male contraceptive which science seems to have completely overlooked: the natural "charm" of most men!

Tagged

birth control

contraceptives

male contraceptives

risug

science


Ben Yakas

Ben Yakas is a former Gothamist reporter.

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets

The U.S. Attorney’s Office of New Jersey says the clinical lab operator provided free entertainment to clients in exchange for business referrals for services that were then paid back through Medicare and Medicaid.

By

Kaya Laterman

Published Nov 7, 2026 at 10:21 a.m. ET


Person found dead with stab wounds in Queens building, NYPD says

Police hadn't yet named and suspects or identified the victim Friday.

By

Giulia Heyward

News

Person found dead with stab wounds in Queens building, NYPD says

Police hadn't yet named and suspects or identified the victim Friday.

By

Giulia Heyward


Amtrak's Penn Station plan could funnel taxpayer money to new venue for James Dolan

By

Ramsey Khalifeh

Intoxicated Queens driver killed baby after running stop sign, indictment says

By

Giulia Heyward

Man arrested in NYC on accusations of sexual assault, rape on Cape Cod, officials said

By

Brittany Kriegstein


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .